Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)
National Institutes of Health (NIH)
Maximum funding period of 5 years, with up to 2 years for R61 phase and up to 3 years for R33 phase.
Support clinical research applications that are exploratory and developmental in nature focusing on understanding neurobiological mechanisms underlying substance use disorders (SUD).
Researchers in the field of neuroscience and substance use disorders, and ultimately individuals affected by SUD.
NIH funding through the National Institute on Drug Abuse (NIDA).
Grant: A support mechanism providing money, property, or both to an eligible entity.
Recurring grant opportunity with multiple application deadlines.
Higher Education Institutions
Public/State Controlled Institutions of Higher Education
Private Institutions of Higher Education
Nonprofits Other Than Institutions of Higher Education
For-Profit Organizations
Small Businesses
Local Governments
State Governments
County Governments
City or Township Governments
Indian/Native American Tribal Governments (Federally Recognized)
Federal Government
Foreign Institutions
All PD(s)/PI(s) must have an eRA Commons account.
Eligible organizations can be domestic or foreign.
Not specified.
Understanding neurobiological mechanisms underlying substance use disorders.
Development of novel techniques, agents, methodologies, models, or applications that could have a major impact on SUD research.
Applicants must demonstrate skills and knowledge necessary to carry out the proposed research.
For the R61 phase, the combined budget for direct costs for up to two years may not exceed $500,000.
For the R33 phase, budgets are not limited but must reflect the actual needs of the proposed project.
Open Date: May 21, 2023.
Application Due Dates: Multiple deadlines from June 21, 2023, to March 13, 2026.
All applications must comply with NIH Grants Policy Statement.
Applications must follow the instructions in the SF424 (R&R) Application Guide.
Applications must propose basic science experimental studies involving humans.